autologous thytreg
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2013 (NCT03162237)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04924491 | Phase 1/Phase 2 (Phase 2) | Sep 10, 2020 | Fundación Familia Alonso, Hospital General Universitario Gregorio Marañon, Universidad Carlos III Madrid |
| NCT03162237 | N/A | Jul 31, 2013 | Central South University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Central South University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Fundación Familia Alonso | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Hospital General Universitario Gregorio Marañon | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Universidad Carlos III Madrid | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1